National and Kapodistrian University of Athens
Σύγκριση της διαδερμικής διά της υποκλειδίου αρτηρίας σε σχέση με τη διαμηριαία προσπέλαση τοποθέτηση αορτικής βαλβίδας σε ασθενείς με στένωση αορτικής βαλβίδος
Abstract
dc:descriptionIntroduction: Transcatheter aortic valve implantation (TAVI) represents a challengingtherapeutic alternative for patients with severe aortic stenosis at high surgical risk. Arelevant number of TAVI candidates cannot undergo the standard transfemoral vascularaccess due to unfavourable iliofemoral anatomy or extensive atherosclerotic disease. Inthese patients, a trans-subclavian approach may be feasible.Aim: Our aim was to prospectively assess the safety and efficacy of the trans-subclavianapproach for TAVI, as compared with the transfemoral approach.Methods and results: We included 193 patients, who all underwent a percutaneous aorticvalve implantation between June 2008 and February 2015. The subclavian approach wasused in 36 cases (18.7%). The logistic Euro Score was significantly higher in the subclavianvs. femoral group (30.88 ± 10.8 vs. 25.78 ± 10.1; p = 0.009), as well as lower body massindex (24.29 ± 3.4 % vs. 26.91 ± 3.9%; p = 0.001), rate of peripheral artery disease (94.4vs. 32.7%, P <0.001) and rate of patients with low flow - low gradient severe aortic stenosis(34.3 vs.14.0%; p = 0.004). Procedural success was equally obtained in 97.2 vs. 94.9% ofthe subclavian vs. femoral groups, respectively (p = 0.876), with higher use of generalanaesthesia (94.4 to 41.4%; p < 0.001) and intraprocedural mortality of 2.8% vs. 0.6% (p =0.339). Need for permanent pacemaker implantation (41.4 vs. 36.9%; p = 0.654), acutekidney disease stage I–II (36.10% to 34.40%; p < 0.846) and major bleeding complications(36.10 to 34.60%; p = 0.865) were the most common in-hospital complications. But theincidence was not different between the two groups. However, acute myocardial injury (46.4to 23.5%; p = 0.014) and vascular complications (8.3 to 27.4%; p=0.016) were observedmore frequently in the subclavian approach. No specific serious complications related tosubclavian access (vessel rupture, vertebral or internal mammary ischaemia, brachialplexus injury) were reported. The prevalence of more than mild paravalvular leak atdischarge was 14.3 vs. 13.0% in the subclavian vs. femoral group, respectively (p = 0.838).Thirty-day mortality was 8.34 vs. 3.2% (p = 0.179) and one year mortality was 13.9 vs.10.8% in the subclavian vs. femoral group (p = 0.594), respectively. Acute kidney injury andmoderate/ severe paravalvular regurgitation (PVR) appeared to be independent predictorsof 1 year mortality.Conclusions: Subclavian approach is a feasible and safe option for TAVI, providingexcellent procedural success and low in-hospital complication rates. Our findings suggestthat this approach should be considered as a valid alternative both for patients with animpossible femoral approach and also for those imposing a difficult but still feasible access.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2017
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Thomopoulou, Sofia
- Θωμοπούλου, Σοφία
Subjects
dc:subject × 14- Υποκλείδιος αγγειακή προσπέλαση
- Διακαθετηριακή αντικατάσταση αορτικής βαλβίδας
- Στένωση αορτικής βαλβίδας
- Transcatheter aortic valve implantation (TAVI)
- Trans-subclavian approach for TAVI
- Aortic stenosis
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Επιστήμες Υγείας
- Ιατρική Βιοτεχνολογία
- Medical and Health Sciences
- Clinical Medicine
- Health Sciences
- Medical Biotechnology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/40346